Sulfonamide – Sulphanilamidum

The attenuations are prepared from Sulfanilamide, C₆H₈N₂O₂ S, MW: 172.2 (Poten- tised allopathic compound).

The main indications are:

Iatrogenic damage of all kinds, particularly agranulocytosis, post-infectious anaemia, connective tissue lesions (bad posture of growing young people following previous chemotherapy with consequent Scheuermann’s disease or osteochondrosis). Auto-immune diseases, liver damage. Myocarditis. May be tried experimentally in nephrosis and intransigent sleeplessness. Neurasthenia.